Skip to content

Clinical trials

Phase 3 Ischemic Attack, Transient trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Attack, Transient Phase: Phase 3 Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20032
20072
20081
20091
20101
20111
20121
20142
20152
20161
20182
20191
20201
20211
20241
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated4
Not yet recruiting2
Unknown status2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Bayer3
Beijing Tiantan Hospital3
Assistance Publique - Hôpitaux de Paris2
Asan Medical Center1
Boston Scientific Corporation1
Capital Medical University1
Hanyang University Guri Hospital1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Mazandaran University of Medical Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Attack, Transient28
Stroke18
Ischemic Stroke8
Atherosclerosis2
Atrial Fibrillation2
Carotid Stenosis2
Cerebral Infarction2
Cerebrovascular Disorders2
Ischemia2
Thromboembolism2

Trials

Showing 76 to 28 of 28. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.